共 50 条
- [4] Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial [J]. LANCET NEUROLOGY, 2012, 11 (07): : 579 - 588
- [5] Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial [J]. LANCET NEUROLOGY, 2017, 16 (01): : 43 - 54
- [7] LONG-TERM SAFETY AND EFFICACY OF ZONISAMIDE VERSUS CARBAMAZEPINE MONOTHERAPY FOR TREATMENT OF PARTIAL SEIZURES IN ADULTS WITH NEWLY DIAGNOSED EPILEPSY: RESULTS OF A PHASE III, MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
- [8] Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy [J]. ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 (03): : 165 - 175